Renin-angiotensin system (RAS) activation reportedly induces intrarenal haemodynamic abnormalities in diabetes, the intrarenal RAS may be activated in diabetes and subsequently facilitate increases in the RI, and blocking RAS activation with captopril may reduce intrarenal vascular resistance in diabetes [23, 24]. The gene discussed is REN; the disease is diabetes mellitus.